- Home
- UNB vs COYA Comparison
UNB vs COYA Comparison
Compare UNB & COYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | UNB | COYA |
|---|---|---|
| Founded | 1891 | 2020 |
| Country | United States | United States |
| Employees | 195 | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 120.9M | 124.8M |
| IPO Year | 1999 | 2022 |
Fundamental Metrics
Financial Performance| Metric | UNB | COYA |
|---|---|---|
| Price | $25.88 | $5.37 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $15.80 |
| AVG Volume (30 Days) | 6.5K | ★ 177.2K |
| Earning Date | 04-15-2026 | 05-08-2026 |
| Dividend Yield | ★ 5.76% | N/A |
| EPS Growth | ★ 25.52 | N/A |
| EPS | ★ 0.65 | N/A |
| Revenue | N/A | ★ $7,945,753.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $763.10 |
| P/E Ratio | $40.31 | ★ N/A |
| Revenue Growth | N/A | ★ 123.57 |
| 52 Week Low | $20.65 | $3.71 |
| 52 Week High | $29.49 | $7.75 |
Technical Indicators
Market Signals| Indicator | UNB | COYA |
|---|---|---|
| Relative Strength Index (RSI) | 62.80 | 63.35 |
| Support Level | $23.87 | $5.18 |
| Resistance Level | $25.63 | $6.22 |
| Average True Range (ATR) | 0.60 | 0.35 |
| MACD | 0.28 | 0.06 |
| Stochastic Oscillator | 65.99 | 96.67 |
Price Performance
Historical ComparisonAbout UNB Union Bankshares Inc.
Union Bankshares Inc operates as a community bank in the financial services industry. It offers retail and commercial banking services to its customers through its branches, ATMs, telebanking, and internet banking systems. The Company has one definable business segment, Union Bank, which provides full retail, commercial, municipal banking, and wealth management and trust services throughout its 18 branch banking locations, three loan centers, and several ATMs covering northern Vermont and northern New Hampshire. In addition, it also offers fiduciary and asset management services through its Asset Management Group.
About COYA Coya Therapeutics Inc.
Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary new therapies to enhance the function of regulatory T cells (Tregs). The company's initial development programs are focused on neurodegenerative, chronic inflammatory, autoimmune, and metabolic diseases with high unmet medical needs.